Approval · Notice of Compliance 32597 · 2024
APTIOM: Notice of Compliance 32597
Issued January 25, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32597
- Date
- January 25, 2024
- Company
- Sumitomo Pharma Canada, Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Manufacturer Name Change
Products in this notice
Medicinal ingredients
- ESLICARBAZEPINE ACETATE 200 MG per TAB
- ESLICARBAZEPINE ACETATE 400 MG per TAB
- ESLICARBAZEPINE ACETATE 600 MG per TAB
- ESLICARBAZEPINE ACETATE 800 MG per TAB